S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

PVCT Provectus Biopharmaceuticals Inc (QB)

0.1182

-0.0017 (-1.42%)

Nov 25 2024 - Closed

Delayed by 15 minutes

Form D - Notice of Exempt Offering of Securities

Provectus Biopharmaceuti... (QB) (USOTC:PVCT)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Provectus Biopharmaceuti... (QB) Charts.

Provectus Biopharmaceuti... (QB) (USOTC:PVCT)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Provectus Biopharmaceuti... (QB) Charts.

Provectus Biopharmaceuticals Inc (QB) News

Form 4 - Statement of changes in beneficial ownership of securities
Monday 25 November 2024 (6 hours ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 14 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 12 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 17 October 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 30 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 30 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 30 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 30 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 30 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 20 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 30 August 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 27 August 2024 (3 months ago) • Edgar (US Regulatory)

More Provectus Biopharmaceuticals Inc (QB) News Articles

Anavex Life Sciences

Global Developments (PK)

GNCC Capital (CE)

Digital Brand Media and ... (PK)

Asia Broadband (PK)

Accredited Solutions (PK)

TransCode Therapeutics

Code Green Apparel (PK)

Quantum Computing

Super Micro Computer

FuelCell Energy

Clean Vision (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions